Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Department of Herbal Medicine, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Biomed Res Int. 2021 Nov 30;2021:6002286. doi: 10.1155/2021/6002286. eCollection 2021.
Polymeric materials from plants continue to be of interest to pharmaceutical scientists as potential binders in immediate release tablets due to availability, sustainability, and constant supply to feed local pharmaceutical industries. Paracetamol tablet formulations were utilized in investigating the potential binding characteristics of pectin harnessed from various okra genotypes (PC1-PC5) in Ghana. The pectin yields from the different genotypes ranged from 6.12 to 18.84%w/w. The pH of extracted pectin ranged from 6.39 to 6.92, and it had good swelling indices and a low moisture content. Pectin extracted from all genotypes were evaluated as binders (10, 15, and 20%w/v) and compared to tragacanth BP. All formulated tablets (F1-F18) passed the weight uniformity, drug content, hardness, and friability tests. Based on their crushing strength, tablets prepared with pectin from the various genotypes were relatively harder ( ≤ 0.05) than tablets prepared with tragacanth BP. Tablets prepared with pectins as binders at 10%w/v and 15%w/v passed the disintegration and dissolution tests with the exception of PC4 at 15%w/v. Incorporation of pectin from all genotypes (excluding PC5) as a binder at concentrations above 15%w/v (F13, F16, F14, and F15) produced tablets which failed the disintegration test and showed poor dissolution profiles. Thus, pectin from these genotypes can be industrially commodified as binders in immediate release tablets using varying concentrations.
植物来源的聚合物材料由于其可用性、可持续性和为当地制药工业提供持续供应的能力,继续引起制药科学家的兴趣,作为速释片剂的潜在粘合剂。利用对乙酰氨基酚片剂配方来研究从加纳各种秋葵基因型(PC1-PC5)中获得的果胶的潜在结合特性。不同基因型的果胶产率范围为 6.12%至 18.84%w/w。提取果胶的 pH 值范围为 6.39 至 6.92,具有良好的溶胀指数和低水分含量。从所有基因型中提取的果胶均被评估为粘合剂(10%、15%和 20%w/v),并与黄蓍胶 BP 进行比较。所有配制的片剂(F1-F18)均通过了重量均匀性、药物含量、硬度和脆碎度测试。根据其抗压强度,用各种基因型果胶制备的片剂相对较硬(≤0.05),比用黄蓍胶 BP 制备的片剂硬。以 10%w/v 和 15%w/v 作为粘合剂配制的片剂除了在 15%w/v 时的 PC4 以外,均通过了崩解和溶解测试。除了 PC5 之外,所有基因型的果胶(不包括 PC5)作为粘合剂的浓度超过 15%w/v(F13、F16、F14 和 F15)会导致片剂崩解测试失败,并表现出较差的溶解曲线。因此,这些基因型的果胶可以在工业上通过使用不同的浓度来商品化,作为速释片剂中的粘合剂。